title: Pilot clinical trial of the combination of hydroxyurea and didanosine in HIV-1 infected individuals.
authors.affiliation: Service des Maladies Infectieuses et Tropicales, Hôpital de la Croix Rousse, Lyon, France.
authors.forename: F
authors.initials: F
authors.lastname: Biron
authors.forename: F
authors.initials: F
authors.lastname: Lucht
authors.forename: D
authors.initials: D
authors.lastname: Peyramond
authors.forename: A
authors.initials: A
authors.lastname: Fresard
authors.forename: T
authors.initials: T
authors.lastname: Vallet
authors.forename: F
authors.initials: F
authors.lastname: Nugier
authors.forename: J
authors.initials: J
authors.lastname: Grange
authors.forename: S
authors.initials: S
authors.lastname: Malley
authors.forename: F
authors.initials: F
authors.lastname: Hamedi-Sangsari
authors.forename: J
authors.initials: J
authors.lastname: Vila
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D016049:Didanosine / Q000009:adverse effects* / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005602:France; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000254:growth & development; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects* / Q000627:therapeutic use*; D007963:Leukocytes, Mononuclear / Q000821:virology; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D012367:RNA, Viral / Q000097:blood
chemical_list: D000970:Antineoplastic Agents; D000998:Antiviral Agents; D012367:RNA, Viral; D016049:Didanosine; D006918:Hydroxyurea